Immunomodulatory treatment trial for paraneoplastic neurological disorders

Neuro-Oncology

Volumn 6, Issue 1, 2004, Pages 55-62

  Vernino, Steven ^a   O'Neill, Brian Patrick ^a   Marks, Randolph S ^a   O'Fallon, Judith R ^a   Kimmel, David W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; DISEASE DURATION; DRUG TOLERABILITY; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTOPENIA; MALE; NAUSEA; NEUTROPENIA; OPEN STUDY; OUTCOMES RESEARCH; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; VOMITING;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTINEOPLASTIC AGENTS; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROSPECTIVE STUDIES;

EID: 0942277092     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000395     Document Type: Article

References (36)

1. Albert, M.L., Darnell, J.C., Bender, A., Francisco, L.M., Bhardwaj, N., and Darnell, R.B. (1998) Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 4, 1321-1324.
2. Albert, M.L., Austin, L.M., and Darnell, R.B. (2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann. Neurol. 47, 9-17.
3. Bataller, L., Graus, F., Saiz, A., Vilchez, J.J., and Spanish Opsoclonus-Myoclonus Study G (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124, 437-443.
4. Batchelor, T.T., Flatten, M., and Hochberg, F.H. (1998) Immunoadsorption therapy for paraneoplastic syndromes. J. Neurooncol. 40, 131-136.
5. Batson, O.A., Fantle, D.M., and Stewart, J.A. (1992) Paraneoplastic encephalomyelitis. Dramatic response to chemotherapy alone. Cancer 69, 1291-1293.
6. Blaes, F., Strittmatter, M., Merkelbach, S., Jost, V., Klotz, M., Schimrigk, K., and Hamann, G.F. (1999) Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J. Neurol. 246, 299-303.
7. Bruyland, M., Van Belle, S., Schallier, D., Ebinger, G., and Martin, J.J. (1984) Good response of a paraneoplastic neuromyopathy to cyclophosphamide. Cancer Treat. Rep. 68, 787-789.
8. Cocconi, G., Ceci, G., Juvarra, G., Minopoli, M.R., Cocchi, T., Fiaccadori, F., Lechi, A., and Boni, P. (1985) Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. A case report. Cancer 56, 2318-2320.
9. Counsell, C.E., McLeod, M., and Grant, R. (1994) Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurology 44, 1184-1185.
10. Dalmau, J.O., and Posner, J.B. (1997) Paraneoplastic syndromes affecting the nervous system. Semin. Oncol. 24, 318-328.
11. David, Y.B., Warner, E., Levitan, M., Sutton, D.M., Malkin, M.G., and Dalmau, J.O. (1996) Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report. Cancer 78, 2153-2156.
12. Dropcho, E.J. (1995) Autoimmune central nervous system paraneoplastic disorders: Mechanisms, diagnosis, and therapeutic options. Ann. Neurol. 37, S102-S113.
13. Faris, M., Abraham, J., and Barrett-Lee, P. (1998) A patient with breast cancer and paraneoplastic cerebellar syndrome associated with anti-Purkinje cell antibodies: Response to CMF chemotherapy. Clin. Oncol. (R. Coll. Radiol.) 10, 202-203.
14. Glantz, M.J., Biran, H., Myers, M.E., Gockerman, J.P., and Friedberg, M.H. (1994) The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 73, 168-175.
15. Graus, F., Dalmou, J., Rene, R., Tora, M., Malats, N., Verschuuren, J.J., Cardenal, F., Vinolas, N., Garcia del Muro, J., Vadell, C., Mason, W.P., Rosell, R., Posner, J.B., and Real, F.X. (1997) Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival. J. Clin. Oncol. 15, 2866-2872.
16. Graus, F., Keime-Guibert, F., Rene, R., Benyahia, B., Ribalta, T., Ascaso, C., Escaramis, G., and Delattre, J.Y. (2001) Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients. Brain 124, 1138-1148.
17. Graus, F., Vega, F., Delattre, J.Y., Bonaventura, I., Rene, R., Arbaiza, D., and Tolosa, E. (1992) Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42, 536-540.
18. Grisold, W., Drlicek, M., Liszka-Setinek, U., and Wondrusch, E. (1995) Anti-tumour therapy in paraneoplastic neurological disease. Clin. Neurol. Neurosurg. 97, 106-111.
19. Guy, J., and Aptsiauri, N. (1999) Treatment of paraneoplastic visual loss with intravenous immunoglobulin: Report of 3 cases. Arch. Ophthalmol. 117, 471-477.
20. Jaeckle, K.A. (1996) Paraneoplastic nervous system syndromes. Curr. Opin. Oncol. 8, 204-208.
21. Keime-Guibert, F., Graus, F., Fleury, A., Rene, R., Honnorat, J., Broet, P., and Delattre, J.Y. (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J. Neurol. Neurosurg. Psychiatr. 68, 479-482.
22. Lennon, V.A. (1994) Paraneoplastic autoantilbodies: The case for a descriptive generic nomenclature. Neurology 44, 2236-2240.
23. Mahoney, F., and Barthel, D. (1965) Functional evaluation: The Barthel index. MD State Med. J. 14, 61-65.
24. Moll, J.W., Henzen-Logmans, S.C., Van der Meche, F.G., and Vecht, C.H (1993) Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration [comment]. J. Neurol. Neurosurg. Psychiatr. 56, 112.
25. Mowzoon, N., and Bradley, W.G. (2000) Successful immunosuppressant therapy of severe progressive cerebellar degeneration and sensory neuropathy: A case report. J. Neurol. Sci. 178, 63-65.
26. NCI. National Cancer Institute (1999) Common Toxicity Criteria version 2.0. Available at https://webapps.ctep.nci.nih.gov/ctcv2/plsql/ctc000w$.startup.
27. Oh, S.J., Slaughter, R., and Harrell, L. (1991) Paraneoplastic vasculitic neuropathy: A treatable neuropathy. Muscle Nerve 14, 152-156.
28. Oh, S.J., Dropcho, E.J., and Claussen, G.C. (1997) Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: Report of two cases and review of literature. Muscle Nerve 20, 1576-1582.
29. Rankin, J. (1957) Cerbral vascular accidents in patients over the age of 60: II. Prognosis. Scott. Med. J. 2, 200-215.
30. Rickman, O.B., Parisi, J.E., Yu, Z., Lennon, V.A., and Vernino, S. (2000) Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange. Mayo Clin. Proc. 75, 1321-1326.
31. Rojas, I., Graus, F., Keime-Guibert, F., Rene, R., Delattre, J.Y., Ramon, J., Dalmau, J., Posner, J.B. (2000) Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55, 713-715.
32. Schmierer, K., Valdueza, J.M., Bender, A., DeCamilli, P., David, C., Solimena, M., and Zschenderlein, R. (1998) Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression. Neurology 51, 250-252.
33. Sillevis Smitt, P., Grefkens, J., de Leeuw, B., van den Bent, M., van Putten, W., Hooijkaas, H., and Vecht, C. (2002) Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J. Neurol. 249, 745-753.
34. Stark, E., Wurster, U., Patzold, U., Sailer, M., and Haas, J. (1995) Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch. Neurol. 52, 814-818.
35. Uchuya, M., Graus, F., Vega, F., Rene, R., and Delattre, J.Y. (1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J. Neurol. Neurosurg. Psychiatr. 60, 388-392.
36. Weissman, D.E., and Gottschall, J.L. (1989) Complete remission of paraneoplastic sensorimotor neuropathy: A case associated with small-cell lung cancer responsive to chemotherapy, plasma exchange, and radiotherapy. J. Clin. Apheresis 5, 3-6.